Influence of hormonal stimulation and intermittent cold exposure on the mechanisms of formation of polycystic ovarian syndrome
Abstract
Introduction. Polycystic ovary syndrome (PCOS) is one of the most pressing problems in gynecological endocrinology. The aim of the study was to elucidate the morphological changes in the ovaries of rats under various types of hormonal exposure in experimental modeling of PCOS. Materials and methods. To study three working experimental models were developed, associated with the introduction of various hormonal drugs into the body of an animal. Model I-st consisted of subcutaneous administration of an estrogen-containing drug at a dose of 3 mg for 25 days. Model II-d involved the development of PCOS by daily subcutaneous administration of 3 mg of dehydroandrostenediol sulfate. The III model - the formation of PCOS in 5 immature rats using dopamine phytoanalogues at a dose of 3 mg subcutaneously for 25 days. The animals were divided into 3 groups: group 1 - rats that were induced with experimental PCOS and kept in a vivarium at a temperature of +23°C (n=8), group 2 - animals that, against the background of experimental PCOS, were exposed to cold exposure (CE) for 4 hours in a chamber with a constant light regime and a temperature of + 4 °C for 25 days (n = 8); group 3 - intact control (n = 8) - healthy rats without PCOS, which were kept in a vivarium at a temperature of + 23°C. Results. Histological examination of the ovaries of group 1 rats revealed morphological changes in the ovaries characteristic of PCOS. The morphological structure of the ovaries corresponded to type II PCOS. In rats of group 3, macroscopically, the ovaries were slightly reduced in size compared to the control group. The levels of adiponectin and leptin as markers of the functional ovarian tissue of PCOS model experiments.When studying the effect of CE on the body of experimental animals, their effect on the formation of tissue cell hyperplasia as a characteristic sign of PCOS was determined. Conclusions. Studies have shown that the formation of PCOS, as well as structural changes in the ovaries, significantly depend on hormonal regulation disorders.
Downloads
References
Urbanovych AM. Syndrom polikistoznykh yaiechnykiv u shchodennii praktytsi. Mizhnarodnyi endokrynolohichnyi zhurnal. 2018;1(14):40-45. DOI: 10.22141/2224-0721.14.1.2018.127090. [Ukrainian].
Couto Alves A, Valcarcel B, Mäkinen VP, Morin-Papunen L, Sebert S, Kangas AJ, et al. Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity. Int J Obes (Lond). 2017; 41(9):1331-1340. DOI: 10.1038/ijo.2017.126.
Mogylnytska LA. Vascular endothelial growth factor and endotheliumdependent dilatation in patients with polycystic ovary syndrome whith different body mass. Zhurnal NAMN Ukrayiny`, 2018; Special`ny`j vy`pusk:22-23. [Ukrainian]
Kakoly NS, Moran LJ, Teede HJ, Joham AE. Cardiometabolic risks in PCOS: a review of the current state of knowledge. Expert Rev Endocrinol Metab. 2019;14(1):23-33.
Dokras A, Stener-Victorin E, Yildiz BO. et al. Androgen Excess-Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil.Steril. 2018;109(5):888-899. DOI: 10.1016/j.fertnstert.2018.01.038.
Kuzmina IYu, Nikolayeva OV, Zhulikova MV. Patent 3527 Ukraine, MPK G09B 23/28(2006.01). Sposib modelyuvannya sindromu polikistoznikh yayechnikiv / № u2017 0352711/04/17; opubl.07.08.2017. [Ukrainian].
Qin JC, Fan L, Qin AP. The effect of dehydroepiandrosterone (DHEA) supplementation on women with diminished ovarian reserve (DOR) in IVF cycle: Evidence from a meta-analysis. J Gynecol Obstet Hum Reprod. 2017 Jan;46(1):1-7. DOI: 10.1016/j.jgyn.2016.01.002.
Kuz`mina IYu, Zhulikova MV. Dosyagnennya ta perspekty`vy` ekspery`mental`noyi i klinichnoyi endokry`nologiyi (Simnadcyati Dany`levs`ki chy`tannya – Kharkiv. Faktory` ry`zy`ku rozvy`tku sy`ndromu polikistozny`x yayechny`kiv yak predy`ktory` vidnovlennya reprodukty`vnoyi funkciyi. 2018. 78-81s. [Ukrainian].
Tetyura SM, Antonova VO. Vply`v ekstremal`noyi krioterapiyi na funkcional`ny`j stan sercevo-sudy`nnoyi sy`stemy` lyudy`ny`. Py`tannya ekspery`mental`noyi ta klinichnoyi medy`cy`ny`. 2009; 2(13): 72-79. [Ukrainian].
Agacayak E, Tunc SY, Sak S. Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome. Med Sci Monit. 2015;21:2446–2455. [Ukrainian].
Gao T, Wu L, Chang F, Cao G. Low circulating ghrelin levels in women with polycystic ovary syndrome: a systematic review and meta-analysis. Endocr J. 2016;63(1):93-100.
Kuz`mina IYu, Zhulikova MV. Osobly`vosti modernizaciyi predmetu doslidzhen` predstavny`kiv medy`chny`x nauk: zb.naukovy`x pracz` nauk.-prakt. k-ciyi z mizhn. Uchastyu. Vikova dy`namika patomorfologichnoyi perebudovy` yayechny`kiv pry` eksperemental`nomu polikistozi v shhuriv. 2017 chervnya 14-15, 8-12s. Ky`yiv. [Ukrainian].
Kuz`mina IYu, Zhulikova MV. Dosyagnennya ta perspekty`vy` ekspery`mental`noyi i klinichnoyi endokry`nologiyi (Simnadcyati Dany`levs`ki chy`tannya). Endokry`nologichni ta imunologichni osobly`vosti endometriya pry` sy`ndromi polikistozny`x yayechny`kiv. 2018. 82-84s. Kharkiv [Ukrainian].
Barthelmess EK, Naz RK. Polycystic ovary syndrome: current status and future perspective Front. Biosci. (Elite Ed). 2015;6:104-119.
Panigone S, Hsieh M, Fu M, Persani L, Conti M. Luteinizing hormone signaling in preovulatory follicles involves early activation of the epidermal growth factor receptor pathway. Mol Endocrinol. 2008;22(4):924–36
